Caris Life Sciences, Inc. (CAI)
23.04
-0.92
(-3.84%)
USD |
NASDAQ |
Nov 13, 16:00
23.04
0.00 (0.00%)
After-Hours: 19:59
Caris Life Sciences EPS Diluted (Quarterly) : 0.0517 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0517 |
| June 30, 2026 | -0.0022 |
| March 31, 2026 | -0.0018 |
| December 31, 2025 | 0.2901 |
| September 30, 2025 | 0.0862 |
| June 30, 2025 | -1.84 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.452 |
| December 31, 2024 | -0.2204 |
| September 30, 2024 | -0.3287 |
| June 30, 2024 | -0.3194 |
| March 31, 2024 | -0.4772 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.4159 |
| Myriad Genetics, Inc. | -0.4587 |
| BioRestorative Therapies, Inc. | -2.431 |
| CareDx, Inc. | 0.3509 |
| Exagen, Inc. | -0.255 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.25M |
| Revenue (Quarterly) | 275.36M |
| Total Expenses (Quarterly) | 260.11M |
| Enterprise Value | 6.302B |
| Gross Profit Margin (Quarterly) | 66.20% |
| Profit Margin (Quarterly) | 5.54% |
| Earnings Yield | 1.47% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.758 |